156 related articles for article (PubMed ID: 38029050)
1. Assessing Reliability and Validity of the Oxford Depression Questionnaire (ODQ) in a Japanese Clinical Population.
Kato M; Kikuchi T; Watanabe K; Sumiyoshi T; Moriguchi Y; Åström DO; Christensen MC
Neuropsychiatr Dis Treat; 2023; 19():2401-2412. PubMed ID: 38029050
[TBL] [Abstract][Full Text] [Related]
2. The Chinese Version of Oxford Depression Questionnaire: A Validation Study in Patients with Mood Disorders.
Zhu Y; Wu L; Ye S; Fu Y; Huang H; Lai J; Shi C; Hu S
Neuropsychiatr Dis Treat; 2023; 19():547-556. PubMed ID: 36915907
[TBL] [Abstract][Full Text] [Related]
3. Validation of the Oxford Depression Questionnaire: Sensitivity to change, minimal clinically important difference, and response threshold for the assessment of emotional blunting.
Christensen MC; Fagiolini A; Florea I; Loft H; Cuomo A; Goodwin GM
J Affect Disord; 2021 Nov; 294():924-931. PubMed ID: 34378539
[TBL] [Abstract][Full Text] [Related]
4. Goal Attainment Scaling for Depression: Validation of the Japanese GAS-D Tool in Patients with Major Depressive Disorder.
Kato M; Kikuchi T; Watanabe K; Sumiyoshi T; Moriguchi Y; Oudin Åström D; Christensen MC
Neuropsychiatr Dis Treat; 2024; 20():49-60. PubMed ID: 38239870
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of Vortioxetine on Emotional Blunting in Patients with Major Depressive Disorder with inadequate response to SSRI/SNRI treatment.
Fagiolini A; Florea I; Loft H; Christensen MC
J Affect Disord; 2021 Mar; 283():472-479. PubMed ID: 33516560
[TBL] [Abstract][Full Text] [Related]
6. Reliability and validity of the Chinese version of the Oxford Depression Questionnaire (ODQ-Chinese).
Chen J; Chen W; Zhang H; Hong W; Zhang L; Mi W; Qin J; He Y
J Affect Disord; 2022 Sep; 313():278-282. PubMed ID: 35779672
[TBL] [Abstract][Full Text] [Related]
7. Emotional blunting in patients with depression. Part II: relationship with functioning, well-being, and quality of life.
Christensen MC; Ren H; Fagiolini A
Ann Gen Psychiatry; 2022 Jun; 21(1):20. PubMed ID: 35725552
[TBL] [Abstract][Full Text] [Related]
8. Emotional Blunting in Depression in the PREDDICT Clinical Trial: Inflammation-Stratified Augmentation of Vortioxetine With Celecoxib.
Sampson E; Kavakbasi E; Mills NT; Hori H; Schubert KO; Fourrier C; Baune BT
Int J Neuropsychopharmacol; 2024 Mar; 27(3):. PubMed ID: 38441216
[TBL] [Abstract][Full Text] [Related]
9. Validation and Functional Relevance of the Short Form of the Perceived Deficits Questionnaire for Depression for Japanese Patients with Major Depressive Disorder.
Sumiyoshi T; Uchida H; Watanabe K; Oosawa M; Ren H; Moriguchi Y; Fujikawa K; Fernandez J
Neuropsychiatr Dis Treat; 2022; 18():2507-2517. PubMed ID: 36353465
[TBL] [Abstract][Full Text] [Related]
10. Randomized, double-blind, placebo-controlled study to assess the efficacy and safety of vortioxetine in Japanese patients with major depressive disorder.
Inoue T; Sasai K; Kitagawa T; Nishimura A; Inada I
Psychiatry Clin Neurosci; 2020 Feb; 74(2):140-148. PubMed ID: 31725942
[TBL] [Abstract][Full Text] [Related]
11. Validity and test-retest reliability of the Persian version of the Montgomery-Asberg Depression Rating Scale.
Ahmadpanah M; Sheikhbabaei M; Haghighi M; Roham F; Jahangard L; Akhondi A; Sadeghi Bahmani D; Bajoghli H; Holsboer-Trachsler E; Brand S
Neuropsychiatr Dis Treat; 2016; 12():603-7. PubMed ID: 27022265
[TBL] [Abstract][Full Text] [Related]
12. Using the Goal Attainment Scale adapted for depression to better understand treatment outcomes in patients with major depressive disorder switching to vortioxetine: a phase 4, single-arm, open-label, multicenter study.
McCue M; Sarkey S; Eramo A; François C; Parikh SV
BMC Psychiatry; 2021 Dec; 21(1):622. PubMed ID: 34895181
[TBL] [Abstract][Full Text] [Related]
13. Exploratory study of association between blood immune markers and cognitive symptom severity in major depressive disorder: Stratification by body mass index status.
Fourrier C; Sampson E; Hori H; Schubert KO; Clark S; Mills NT; Baune BT
Brain Behav Immun; 2020 Aug; 88():242-251. PubMed ID: 32526448
[TBL] [Abstract][Full Text] [Related]
14. Validation of the Japanese version of the Pediatric Quality of Life Inventory (PedsQL) Cancer Module.
Tsuji N; Kakee N; Ishida Y; Asami K; Tabuchi K; Nakadate H; Iwai T; Maeda M; Okamura J; Kazama T; Terao Y; Ohyama W; Yuza Y; Kaneko T; Manabe A; Kobayashi K; Kamibeppu K; Matsushima E
Health Qual Life Outcomes; 2011 Apr; 9():22. PubMed ID: 21477361
[TBL] [Abstract][Full Text] [Related]
15. The reliability and validity of PHQ-9 in patients with major depressive disorder in psychiatric hospital.
Sun Y; Fu Z; Bo Q; Mao Z; Ma X; Wang C
BMC Psychiatry; 2020 Sep; 20(1):474. PubMed ID: 32993604
[TBL] [Abstract][Full Text] [Related]
16. Emotional blunting in patients with depression. Part III: relationship with psychological trauma.
Christensen MC; Ren H; Fagiolini A
Ann Gen Psychiatry; 2022 Jun; 21(1):21. PubMed ID: 35729621
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of vortioxetine in patients with major depressive disorder and comorbid Alzheimer's disease in routine clinical practice: An analysis of a post-marketing surveillance study in South Korea.
Cumbo E; Adair M; Åstrom DO; Christensen MC
Front Aging Neurosci; 2022; 14():1037816. PubMed ID: 36698860
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Hamilton Depression Rating Scale and Montgomery-Åsberg Depression Rating Scale: Baked Straight From a Randomized Study.
Santi NS; Biswal SB; Naik BN; Sahoo JP; Rath B
Cureus; 2023 Sep; 15(9):e45098. PubMed ID: 37842359
[TBL] [Abstract][Full Text] [Related]
19. [Validation of the Spanish versions of the Montgomery-Asberg depression and Hamilton anxiety rating scales].
Lobo A; Chamorro L; Luque A; Dal-Ré R; Badia X; Baró E;
Med Clin (Barc); 2002 Apr; 118(13):493-9. PubMed ID: 11975886
[TBL] [Abstract][Full Text] [Related]
20. A 6-Month Open-Label Study of Vortioxetine among Cancer Patients with Major Depressive Disorder (MDD).
Ng CG; Abousheishaa AA; Low SY; Zainal NZ; Thong KS; Awaluddin AB; Loo TH; Yacob SB; Nik Jaafar NR; Abdul Taib NIA; Mohamad Kamal NAB; Ismail F; Zamaniah Wi W
Asian Pac J Cancer Prev; 2023 Aug; 24(8):2583-2591. PubMed ID: 37642043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
